From: A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation
Indicator
xinruibai group
Filgrastim group
P value
Expenses of GCFS injection
214.79 ± 0.00
257.11 ± 61.87
< 0.001
Total hospitalization cost
26,949.77 ± 11,600.97
28,930.52 ± 11,973.67
> 0.05